Skip to main content
OpenTrials

Clinical trial condition

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer

Explore clinical trials studying Metastatic gpNMB Over-expressing Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer trial results

Completed

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

NCT01997333

Conditions
Breast Diseases, Breast Neoplasms, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, +5 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Cancer Research Insititute Mobile, Alabama, United States
  • Arizona Cancer Research Alliance Glendale, Arizona, United States
View all 140 locations
View Trial Details

Related conditions